Strides Shasun receives USFDA Approval

1 Jun 2017

Strides Shasun Limited announced that it has received approval from the United States Food & Drug Administration (USFDA) for Memantine Hydrochloride Tablets USP, 5 mg and 10 mg. The product will be manufactured at the Company’s flagship facility at Bangalore and marketed by Strides Pharma Inc in the US Market. The product will be launched immediately. (EOIC)